Overcoming resistance in Her2-positive metastatic breast cancer

被引：0
|
作者：
Oksuzoglu, Omur Berna [1 ,2 ]
机构：
[1] Erzincan Univ, Fac Med, Dept Internal Med, Med Oncol, Erzincan, Turkey
[2] A Yurtaslan Ankara Oncol Traning & Res Hosp, Dept Med Oncol, Ankara, Turkey
来源：
LEUKEMIA RESEARCH | 2018年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-22
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [21] Therapy of cerebral metastatic, HER2-positive Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2019, 79 (11)
  • [22] Optimizing the Management of Metastatic HER2-Positive Breast Cancer
    Goel S.
    Tolaney S.
    Current Breast Cancer Reports, 2015, 7 (4) : 190 - 202
  • [23] Pertuzumab (Perjeta) for HER2-Positive Metastatic Breast Cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2012, 54 (1395): : 59 - 60
  • [24] Trastuzumab therapy in HER2-positive, metastatic breast cancer
    Smith, A. D.
    Guilbert, K.
    Lister, D.
    Streilein, S.
    Bourrier, V. C.
    Lozar, B.
    Navaratnam, S.
    Harding, G. A.
    Pitz, M. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] Trastuzumab Deruxtecan in HER2-positive metastatic Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (08) : 670 - 670
  • [26] Systemic therapy for metastatic HER2-positive breast cancer
    Bredin, Philip
    Walshe, Janice M.
    Denduluri, Neelima
    SEMINARS IN ONCOLOGY, 2020, 47 (05) : 259 - 269
  • [27] Preclinical and Basic Research Strategies for Overcoming Resistance to Targeted Therapies in HER2-Positive Breast Cancer
    Cao, Yi
    Li, Yunjin
    Liu, Ruijie
    Zhou, Jianhua
    Wang, Kuansong
    CANCERS, 2023, 15 (09)
  • [28] TARGETING THERAPEUTIC RESISTANCE IN HER2-POSITIVE BREAST CANCER
    Goel, Shom
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 82 - 82
  • [29] miRNAs in resistance to lapatinib in HER2-positive breast cancer
    Haley, V.
    Cavicchioli, F.
    Shia, A.
    O'Leary, K.
    Balakrishnan, L.
    Lo Nigro, C.
    Schmid, R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S121 - S121
  • [30] HER2-positive breast cancer
    Loibl, Sibylle
    Gianni, Luca
    LANCET, 2017, 389 (10087): : 2415 - 2429
12345